From next-generation IOLs to tailored refractive strategies, innovation is reshaping how surgeons deliver visual outcomes

Advances presented at ASCRS 2026 highlight a field continuing its transition from procedural success to precision-driven, patient-centred outcomes. Across cataract and refractive surgery, innovation is expanding the therapeutic toolkit, refining intraocular lens (IOL) performance, and improving surgical delivery, ultimately enabling more predictable, personalised visual results. Increasingly, success is defined not only by visual acuity, but by quality of vision, refractive accuracy and long-term patient satisfaction. Together, these developments point to a field evolving at pace, with innovation translating rapidly into clinical practice.

Register now to stay up to date and be the first to receive our latest news, expert perspectives and insights.

Register Register

Expanding the refractive toolbox beyond primary correction

While primary refractive procedures remain central, there is growing recognition that a significant proportion of patients require ongoing optimization after initial surgery. This has driven interest in both pharmacologic and surgical solutions that address residual refractive error and visual quality symptoms, particularly in patients with prior keratorefractive procedures. Discussions comparing modern LASIK with lenticule extraction techniques reinforced how procedural choice is increasingly tailored to individual corneal profiles, visual goals, and the management of complex cases.

Abstract highlight: Treating night vision disturbances after refractive surgery with pharmacologic therapy
Phentolamine ophthalmic solution 0.75% demonstrated potential as a safe and effective treatment for night vision disturbances following keratorefractive surgery. Over a 6-week period, patients experienced improved mesopic low-contrast vision without evidence of tachyphylaxis, offering a promising pharmacologic option for an underserved group. Read the full abstract here

Abstract highlight:  Lenticule transplantation emerges as a durable solution for post-LASIK residual error
Five-year outcomes support lenticule transplantation as a durable solution for residual hyperopia and presbyopia after LASIK. Sustained improvements in both distance and near vision, alongside stable corneal morphology and no reported complications, highlight the growing role of additive corneal procedures. Read the full abstract here

→ Read now: ASCRS 2026: OmniVu shape-changing IOL shows sustained performance at 36 months

Next-generation and adjustable IOLs: toward truly personalized outcomes

IOL development is entering a more mature phase, where the focus is shifting from simply expanding range of vision to optimizing the balance between visual performance, tolerance, and patient experience. At the same time, adjustable lens technologies are introducing a fundamentally different paradigm, one in which refractive outcomes can be refined after surgery, based on real-world patient feedback. Together, these approaches are enabling a more iterative and personalized model of care, particularly in patients with imperfect eyes or complex visual demands.

Abstract highlight: New EDOF designs show increased tolerance to residual refractive error
A purely refractive EDOF IOL demonstrated comparable distance visual acuity and patient satisfaction to monofocal lenses, while offering extended range of vision and high tolerance to residual refractive error, with ≥94% of patients maintaining 20/25 or better vision under defocus conditions. Read the full abstract here

Abstract highlight: Next-generation trifocal lens improves visual quality while maintaining acuity
The Clareon PanOptix Pro lens delivered non-inferior visual acuity across distances compared with its predecessor, with improved patient-reported visual quality and fewer disturbances such as halos and starbursts, suggesting progress in balancing efficacy and visual comfort. Read the full abstract here

Abstract highlight: Early real-world data confirm strong performance of new trifocal IOL technology
Early real-world data show a high proportion of patients achieving 20/20 distance vision and strong near outcomes, reinforcing the refractive predictability and clinical performance of next-generation trifocal technology. Read the full abstract here

Abstract highlight: Adjustable IOL strategies enable postoperative personalization of vision
A mix-and-match strategy using light-adjustable lenses enabled postoperative refractive fine-tuning, with 98.3% of eyes within 0.5 D of target and strong binocular distance and near outcomes, highlighting the potential for tailored spectacle independence. Read the full abstract here

Surgical platform innovation: improving efficiency and control

Although lens technology often dominates discussion, advances in surgical platforms remain critical in translating planning into outcomes. The current focus is on improving fluidics, chamber stability, and energy efficiency, with the aim of reducing surgical trauma and enhancing recovery. Emerging technologies such as digital microscopy are also beginning to reshape intraoperative visualization, while discussions increasingly point toward the future role of surgical robotics and automation alongside established technologies such as femtosecond lasers.

Abstract highlight: Novel phacoemulsification platform demonstrates improved efficiency and chamber stability
The UNITY Vitreoretinal Cataract System demonstrated improved efficiency through 4D ultrasound and advanced fluidics, enabling surgery at lower intraocular pressure with reduced energy use. All patients achieved clear corneas on postoperative day one, with no reported complications, suggesting a strong early safety profile. Read the full abstract here

Long-term outcomes reinforce durability of modern IOL strategies

As the adoption of premium IOLs continues to expand, there is increasing demand for long-term evidence to support their sustained performance. Beyond initial visual outcomes, durability, stability, and patient satisfaction over time are becoming key measures of success.

Abstract highlight: Five-year data confirm sustained performance of trifocal IOLs
This study confirms stable refractive accuracy, high spectacle independence, and strong patient satisfaction over five years, supporting the long-term reliability of trifocal IOL designs. Read the full abstract here

The cataract–retina interface: integrating care across the pathway

Cataract surgery is increasingly being performed in patients with coexisting retinal disease, requiring a more integrated, longitudinal approach to care. Understanding how surgical intervention interacts with ongoing treatments, such as intravitreal injections, is becoming essential to optimizing outcomes.

Abstract highlight: Cataract surgery influences long-term IOP dynamics in patients receiving intravitreal injections
Data from Moorfields Eye Hospital show that while cataract surgery may temporarily reduce IOP spike rates following intravitreal injections, risk increases again over time, reinforcing the need for continued monitoring in these patients. Read the full abstract here

Training and skills development: building confidence with new technologies

Alongside technological innovation, there was strong emphasis on the importance of hands-on training and surgical education, particularly for early-career surgeons. High demand for wet labs, including expanded training in newer techniques such as EVO ICL implantation, reflects the need to build practical confidence as the surgical landscape becomes more complex and technology-driven.